MariMed Announces Second Quarter 2022 Earnings Date

Rhea-AI Summary

MariMed, Inc. (OTCQX: MRMD), a leading cannabis operator, announced plans to report its second quarter 2022 financial results on August 8, 2022, after market close. A conference call will be held on August 9, 2022, at 8:00 a.m. EST to discuss the results. Investors may access the call via MariMed's Investor Relations website, with a playback available for 30 days. MariMed focuses on high-quality cannabis products and operates state-licensed facilities, emphasizing excellence in cultivation and product development.

Positive

• Scheduled reporting of Q2 2022 financial results indicates transparency and commitment to shareholder communication.
• Conference call provides investors direct insight into company performance and future outlook.

Negative

• None.

NORWOOD, Mass., July 11, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its second quarter 2022 financial results on August 8, 2022 after the market closes. Management will host a conference call on August 9, 2022 at 8:00 a.m. EST to discuss financial results.

A webcast will be available and can be accessed via MariMed’s Investor Relations website at https://ir.marimedinc.com. To listen to the live call, please visit the website at least 15 minutes prior to the call to register, download and install any necessary audio software. A playback of the call will be archived on MariMed’s website for approximately 30 days.

About MariMed
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com

Media Contact:
Trailblaze PR
Email: marimed@trailblaze.co

Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com

FAQ

When will MariMed report its Q2 2022 financial results?

MariMed will report its Q2 2022 financial results on August 8, 2022, after market close.

What time is MariMed's conference call for Q2 2022 results?

The conference call will take place on August 9, 2022, at 8:00 a.m. EST.

Where can I access MariMed's Q2 2022 financial results?

You can access MariMed's Q2 2022 financial results on their Investor Relations website.

What is the stock symbol for MariMed?

MariMed's stock symbol is MRMD, traded on the OTCQX.